Verge Genomics is a biotechnology company based in San Francisco, CA, that specializes in leveraging artificial intelligence and genomics to discover new treatments for neurological diseases.
Through their innovative approach, Verge Genomics aims to accelerate the drug discovery process and ultimately improve outcomes for patients suffering from conditions such as Alzheimer's, Parkinson's, and ALS.
Generated from their business information